[Ac225]RTX-2358

N/A

Report date: 2026/02/25 20:02:36

NME

Base Information

Drug Name[Ac225]RTX-2358

Drug Alias Name[Ac 225]RTX-2358[Ac225]RTX-2358

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225Ac +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesRatio Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesRatio Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A